Mostrar el registro sencillo del ítem

Exploring the prevalence of substance-induced neurocognitive disorder among polysubstance users, adding subjective and objective evidence of cognitive impairment

dc.creatorToledo-Fernández, A.es_ES
dc.creatorMarín-Navarrete, R.es_ES
dc.creatorVillalobos-Gallegos, L.es_ES
dc.creatorSalvador-Cruz, J.es_ES
dc.creatorBenjet, C.es_ES
dc.creatorRoncero, C.es_ES
dc.date2020
dc.date.accessioned2023-11-29T17:34:37Z
dc.date.available2023-11-29T17:34:37Z
dc.date.issued2020
dc.identifierJC14SIC20es_ES
dc.identifier.issn0165-1781
dc.identifier.urihttp://repositorio.inprf.gob.mx/handle/123456789/7842
dc.identifier.urihttps://doi.org/10.1016/j.psychres.2020.112944
dc.descriptionThe objective of this study was to explore the prevalence of substance-induced neurocognitive disorder (NCD) in a sample of polysubstance users, adding both objective- and subjective cognitive impairment. Method: We collected cross-sectional data from 33 community-based residential facilities in Mexico City. Montreal Cognitive Assessment was used for measurement of objective cognitive impairment, and a DSM-5-based interview for subjective impairment. Years and days of recent use of alcohol, marijuana, cocaine and inhalants were collected for regression analyses. Results: 753 participants were analyzed; from these, 50.5% show objective impairment, 71% and 58.5% self-reported any cognitive deficit and cognitive decline, respectively. Between 21.8%-36.5% would qualify for NCD when integrating both objective- and subjective impairment (deficit or decline). Significant weak associations were found between objective impairment and subjective deficits in all cognitive domains except social cognition. Regression models adding both objective- and subjective measures explained more variation in the years of alcohol, inhalant and cocaine use, and in recent marijuana use, than the objective measure alone, but associations were inconsistent. Conclusion: Though significant in proportion, the prevalence of NCD in this population can only be partially related to substance use. Further integrative approaches are needed to refine the epidemiology of this disorder.es_ES
dc.formatPDFes_ES
dc.language.isoenges_ES
dc.publisherElsevier/North-Holland Biomedical Presses_ES
dc.relation288:112944
dc.rightsAcceso Cerradoes_ES
dc.titleExploring the prevalence of substance-induced neurocognitive disorder among polysubstance users, adding subjective and objective evidence of cognitive impairmentes_ES
dc.typeArtículoes_ES
dc.contributor.affiliationUniversidad Anáhuac México. Facultad de Psicología. México
dc.contributor.emailaldebaran.toledofe@anahuac.mx (A. Toledo-Fernández)
dc.relation.jnabreviadoPSYCHIATRY RES
dc.relation.journalPsychiatry Research
dc.identifier.placeIrlanda
dc.date.published2020
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
dc.identifier.eissn1872-7123
dc.identifier.doi10.1016/j.psychres.2020.112944
dc.subject.kwNeurocognitive disorder
dc.subject.kwSubjective cognitive impairment
dc.subject.kwMontreal cognitive assessment
dc.subject.kwSubstance use disorder
dc.subject.kwPsychiatric comorbidity


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem